Related Experiment Video
Updated: May 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Cost-effectiveness of the School-Based Asthma Therapy (SBAT) program
Katia Noyes1, Alina Bajorska, Susan Fisher
1Department of Surgery, University of Rochester Medical Center, Rochester, NY 14642, USA. katia_noyes@urmc.rochester.edu
Insights
The School-Based Asthma Therapy (SBAT) program significantly improves asthma symptom-free days for urban children. This asthma intervention is also cost-effective, offering savings compared to usual care.
Area of Science:
- Pediatric Pulmonology
- Public Health Interventions
- Health Economics
Background:
- Urban children face disproportionately high asthma rates.
- Preventive asthma medication underuse is common in this population.
- Existing care models may not adequately address asthma management in schools.
Purpose of the Study:
- To evaluate the cost-effectiveness of the School-Based Asthma Therapy (SBAT) program.
- To compare SBAT with usual care (UC) for pediatric asthma management.
- To assess the impact of school-based asthma interventions on health outcomes and costs.
Main Methods:
- A randomized trial involving 525 urban children (3-10 years) with asthma.
- Intervention group received daily preventive medication at school; control group received usual care.
- Outcomes measured included symptom-free days (SFDs), healthcare costs, and parental productivity losses.
Main Results:
- SBAT yielded approximately 158 additional SFDs per 100 children per 30 days (P < .05).
- The program incurred an additional cost of $4822 per 100 children monthly.
- Net savings of $3240 per 100 children monthly were observed, with an incremental cost-effectiveness ratio of $10 per SFD gained.
Conclusions:
- The School-Based Asthma Therapy (SBAT) program is effective in reducing asthma symptoms in urban children.
- SBAT demonstrates significant cost-effectiveness compared to usual care.
- School-based asthma management programs offer a viable strategy for improving pediatric asthma outcomes.
Background And Objective:
Impoverished urban children suffer disproportionately from asthma and underuse preventive asthma medications. The objective of this study was to examine cost-effectiveness (CE) of the School-Based Asthma Therapy (SBAT) program compared with usual care (UC).
Methods:
The analysis was based on the SBAT trial, including 525 children aged 3 to 10 years attending urban preschool or elementary school who were randomized to either UC or administration of 1 dose of preventive asthma medication at school by the school nurse each school day. The primary outcome was the mean number of symptom-free days (SFDs). The impact of the intervention on medical costs was estimated by using parent-reported child health services utilization data and average national reimbursement rates. We estimated the cost of running the program using wages for program staff. Productivity costs were estimated by using value of parent lost time due to child illness. CE of the SBAT program compared with UC was evaluated based on the incremental CE ratio.
Results:
The health benefit of the intervention was equal to ∼158 SFD gained per each 30-day period (P < .05) per 100 children. The programmatic expenses summed to an extra $4822 per 100 children per month. The net saving due to the intervention (reduction in medical costs and parental productivity, and improvement in school attendance) was $3240, resulting in the incremental cost-savings difference of $1583 and CE of $10 per 1 extra SFD gained.
Conclusions:
The SBAT was effective and cost-effective in reducing symptoms in urban children with asthma compared with other existing programs.
Related Concept Videos
Asthma-IV: Nursing Management
First, in...
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Antiasthma Drugs: β2-Adrenoceptor Agonists
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
Asthma I: Introduction
Asthma III: Clinical Manifestations